Is body height a prognostic marker for outcome of tuberculosis treatment?

Figures & data

Figure 1. Kaplan–Meier survival curves for patients with tuberculosis stratified by sex and body height.

Table 1. Odds ratio (OR) for non-successful treatment outcome and hazard ratio (HR) for mortality during tuberculosis treatment within sex-specific height terciles.

	Male patients^a		Female patients^b
Treatment outcome	Crude OR (95% CI)	Adjusted OR^c (95% CI)	Crude OR (95% CI)	Adjusted OR^c (95% CI)
Short height	Ref.	Ref.	Ref.	Ref.
Medium height	1.25 (0.86–1.80)	1.32 (0.90–1.93)	0.66 (0.38–1.12)	0.68 (0.39–1.17)
Tall height	1.08 (0.74–1.58)	1.22 (0.82–1.82)	1.00 (0.61–1.63)	1.10 (0.66–1.82)
Mortality at end of treatment	Crude HR (95% CI)	Adjusted HR^c (95% CI)	Crude HR (95% CI)	Adjusted HR^c (95% CI)
Short height	Ref.	Ref.	Ref.	Ref.
Medium height	1.33 (0.76–2.33)	1.43 (0.82–2.50)	0.40 (0.18–0.86)	0.41 (0.18–0.86)
Tall height	0.60 (0.30–1.20)	0.77 (0.38–1.57)	0.88 (0.49–1.60)	0.99 (0.55–1.80)

^aMales: N = 1169 for treatment outcome, N = 1176 for mortality.

^bFemales: N = 648 for treatment outcome, N = 647 for mortality.

^cAdjusted for age and HIV-status.